Publications by authors named "P Stepankova"

Claim this Profile
R
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.
Martin Šimkovič, Pavel Vodárek, Monika Motyčková, Dominika Écsiová, Petra Rozsívalová

Eur J Clin Invest· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of elderly patients with classical Hodgkin's lymphoma.
A Sykorova, H Mocikova, M Lukasova, J Koren, P Stepankova

Leuk Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders.
Jana Pospiskova, Lukas Smolej, David Belada, Martin Simkovic, Monika Motyckova, Pavla Stepankova

Orphanet J Rare Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
Heidi Mocikova, Robert Pytlik, Pavla Stepankova, Jozef Michalka, Jana Markova

Acta Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment and prognosis of relapsed or refractory Hodgkin lymphoma patients ineligible for stem cell transplantation].
H Móciková, A Sýkorová, P Stěpánková, J Marková, J Michalka

Klin Onkol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis